Table 2. Study protocol.
Day 0 | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 11 | 4X 21
days cycle |
|
---|---|---|---|---|---|---|---|---|
Lymph node biopsy | X | X | ||||||
Blood and serum samples | X | X | X | |||||
Cytology and histopathology | X | X | ||||||
Valspodar/Placebo (7.5 mg/kg,
PO, q 12 hr) |
X | X | X | X | X | |||
Doxorubicin (21 mg/m 2, IV) | X | |||||||
Doxorubicin (30 mg/m 2, IV) | X |